HRTX Heron Therapeutics, Inc. - Common Stock
$0,31
Fiyat · Ağu 19, 2026
Temel veriler itibarıyla Ağu 10, 2026
52 Haftlık Aralık
$0–$2
0% of range
Analist Derecelendirmesi
BUY
8 analysts
Fiyat Hedefi
$2
+553% upside
P/E (TTM)
-2.6
ROE
312.5%
Net Kâr Marjı
-13.0%
HRTX Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$0.31
Piyasa Değeri
$58M
P/E (TTM)
-2.6
EPS (TTM)
$-0.12
Gelir (TTM)
$155M
Temettü Verimi
—
ROE
312.5%
D/E Borç/Özsermaye
—
52 Haftlık Aralık
$0 – $2
HRTX Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
$155M
2016-12-31
→
2025-12-31
Hisse Başına Kâr
$-0.12
2021-12-31
→
2025-12-31
Serbest Nakit Akışı
$-28M
2016-12-31
→
2025-12-31
Marjlar
-13.0%
2023-12-31
→
2025-12-31
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
HRTX
Akran Ortalaması
P/E (TTM)
-2.6
—
P/S (TTM) (F/S (TTM))
0.4
165.8
P/B (F/D)
4.0
1.6
Price / FCF (Fiyat / Serbest Nakit Akışı)
-2.1
—
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
HRTX
Akran Ortalaması
Gross Margin (Brüt Kar Marjı)
73.3%
71.1%
Operating Margin (Faaliyet Kâr Marjı)
-1.6%
—
Net Profit Margin (Net Kâr Marjı)
-13.0%
-2229.6%
ROA
-8.3%
-64.3%
ROE
312.5%
-102.1%
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
HRTX
Akran Ortalaması
Current Ratio (Cari Oran)
2.5
4.8
Quick Ratio (Cari Oran)
1.2
—
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
HRTX
Akran Ortalaması
Revenue YoY (Gelir Yıllık Bazda)
7.4%
—
Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)
12.9%
—
Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı)
11.8%
—
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
HRTX
Akran Ortalaması
HRTX Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
AL
8 analist
- Güçlü Al 2 25,0%
- Al 4 50,0%
- Tut 2 25,0%
- Sat 0 0,0%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
1 analist · 2026-08-13
Düşük
$2.00
Yüksek
$2.00
Medyan hedef
$2.00
+553,2%
Ortalama hedef
$2.00
+553,2%
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-0.01%
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 30 Haziran 2026 | $-0.03 | $0.01 | -0.04% |
| 31 Mart 2026 | $-0.04 | $-0.02 | -0.02% |
| 31 Aralık 2025 | $-0.02 | $-0.02 | 0.00% |
| 30 Eylül 2025 | $-0.04 | $-0.02 | -0.02% |
| 30 Haziran 2025 | $-0.02 | $-0.01 | -0.01% |
| 31 Mart 2025 | $0.01 | $-0.01 | 0.02% |
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| HRTX | $245M | -10.8 | 7.4% | -13.0% | 312.5% | 73.3% |
| TENX | $114M | -9.1 | — | — | -52.5% | — |
| PMVP | $67M | -0.8 | -40.5% | -1226.8% | -63.4% | — |
| MNOV | $64M | -5.5 | — | -2928.8% | -27.1% | — |
| BOLD | $27M | -0.5 | — | — | -46.7% | — |
| INMB | $41M | -0.8 | 257.1% | -91866.0% | -175.3% | — |
| EXOZ | $92M | -10.0 | — | — | -172.3% | — |
| INKT | — | -3.8 | 4.5% | -6931.8% | 63.4% | — |
| CLNN | $64M | — | -41.5% | -13086.5% | 200.2% | — |
| RNXT | — | -2.6 | 2511.6% | — | — | — |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 17
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $155M | $144M | $127M | $108M | $86M | $89M | $146M | $77M | $31M | $1M | |
| Cost of Revenue | $41M | $39M | $65M | $55M | $46M | $36M | $62M | $28M | $5M | $35.0K | |
| Gross Profit | $114M | $106M | $62M | $53M | · | · | · | · | · | · | |
| R&D Expense | $12M | $17M | $39M | $83M | $131M | $175M | $167M | $140M | $139M | $103M | |
| SG&A Expense | $55M | $53M | $66M | $62M | $40M | $42M | $38M | $29M | $26M | $21M | |
| Operating Expenses | $116M | $117M | $173M | $227M | $304M | $317M | $357M | $261M | $225M | $172M | |
| Operating Income | $-3M | $-12M | $-111M | $-175M | $-218M | $-228M | $-211M | $-184M | $-195M | $-171M | |
| Interest Expense | · | · | $4M | $2M | $2M | $2M | $1M | $3M | $4M | $3M | |
| Interest Income | $2M | $4M | $3M | $2M | $433.0K | $4M | $7M | $6M | $1M | $445.0K | |
| Other Non-op | $1M | $430.0K | $560.0K | $-7M | $-878.0K | $-847.0K | $158.0K | $2M | $-38.0K | $-9.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-20M | $-14M | $-111M | $-182M | $-221M | $-227M | $-205M | $-179M | $-197M | $-173M | |
| EPS (Basic) | $-0.12 | $-0.09 | $-0.80 | $-1.67 | $-2.24 | · | · | · | · | · | |
| EPS (Diluted) | $-0.12 | $-0.09 | $-0.80 | $-1.67 | $-2.24 | · | · | · | · | · | |
| Shares (Basic) | 166,707,000 | 152,449,000 | 138,135,000 | 108,876,000 | 98,471 | · | · | · | · | · | |
| Shares (Diluted) | 166,707,000 | 152,449,000 | 138,135,000 | 108,876,000 | 98,471 | · | · | · | · | · | |
| EBITDA | $-224.0K | $-9M | $-108M | $-172M | $-215M | $-225M | $-209M | $-182M | $-193M | $-171M |
Bilanço 23
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $29M | $26M | $29M | $15M | $91M | $105M | $72M | $32M | $145M | $13M | |
| Short-term Investments | · | · | · | · | · | · | · | $301M | $28M | $38M | |
| Receivables | $90M | $79M | $60M | $52M | $35M | $42M | $40M | $65M | $42M | $2M | |
| Inventory | $93M | $53M | $42M | $55M | $48M | $42M | $25M | $39M | $10M | $5M | |
| Prepaid Expense | $9M | $18M | $6M | $14M | $13M | $22M | $23M | $11M | $4M | $4M | |
| Current Assets | $238M | $209M | $189M | $205M | $254M | $314M | $479M | $447M | $228M | $62M | |
| PP&E (Net) | $12M | $15M | $20M | $22M | $24M | $23M | $20M | $15M | $6M | $5M | |
| PP&E (Gross) | $25M | $33M | $37M | $36M | $37M | $34M | $28M | $23M | $14M | $12M | |
| Accum. Depreciation | $13M | $18M | $17M | $14M | $13M | $11M | $8M | $8M | $8M | $7M | |
| Other Non-current Assets | $5M | $6M | $8M | $16M | $18M | $346.0K | $346.0K | $254.0K | $263.0K | $263.0K | |
| Total Assets | $256M | $233M | $223M | $251M | $306M | $354M | $513M | $462M | $234M | $67M | |
| Accounts Payable | $9M | $12M | $3M | $3M | $4M | $525.0K | $3M | $17M | $19M | $7M | |
| Current Liabilities | $96M | $91M | $80M | $82M | $71M | $103M | $97M | $92M | $103M | $39M | |
| Capital Leases | $0 | · | $3M | $5M | $8M | $15M | $12M | · | · | · | |
| Other Non-current Liabilities | $5M | $615.0K | $241.0K | $241.0K | · | · | · | · | · | · | |
| Total Liabilities | $242M | $267M | $256M | $237M | $228M | $117M | $109M | $92M | $103M | $89M | |
| Common Stock | $2M | $2M | $2M | $1M | $1M | $913.0K | $903.0K | $782.0K | $646.0K | $394.0K | |
| Paid-in Capital | $1.95B | $1.88B | $1.87B | $1.81B | $1.69B | $1.63B | $1.57B | $1.33B | $914M | $564M | |
| Retained Earnings | $-1.94B | $-1.92B | $-1.91B | $-1.80B | $-1.61B | $-1.39B | $-1.17B | $-961M | $-783M | $-586M | |
| AOCI | $4.0K | $13.0K | $13.0K | $-19.0K | $-6.0K | $257.0K | $85.0K | $-87.0K | $-10.0K | $-17.0K | |
| Stockholders' Equity | $14M | $-34M | $-34M | $14M | $78M | $236M | $404M | $370M | $131M | $-21M | |
| Liabilities + Equity | $256M | $233M | $223M | $251M | $306M | $354M | $513M | $462M | $234M | $67M | |
| Shares Outstanding | 188,314,430 | 152,127,878 | 150,285,044 | 119,154,538 | 102,005,000 | 91,310,000 | 90,304,000 | 78,174,000 | 64,609,000 | 39,355 |
Nakit Akışı 13
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | |
| Stock-based Comp | $10M | $13M | $33M | $43M | $47M | $50M | $51M | $33M | $31M | $26M | |
| Restructuring | · | · | · | · | · | $6M | · | · | · | · | |
| Other Non-cash | $-20M | $-24M | $16M | $-11M | $-33M | $-11M | $27M | $-48M | $-5M | · | |
| Operating Cash Flow | $-28M | $-23M | $-59M | $-147M | $-203M | $-185M | $-125M | $-192M | $-170M | $-134M | |
| CapEx | $317.0K | $2M | $2M | $2M | $3M | $7M | $7M | $9M | $3M | $3M | |
| Investing Cash Flow | $16M | $19M | $18M | $-3M | $33M | $209M | $-22M | $-279M | $8M | $15M | |
| Net Debt Issued | · | · | · | · | · | · | · | $-25M | $-25M | · | |
| Stock Issued | $18M | · | $30M | $75M | · | · | $162M | $363M | $306M | · | |
| Net Stock Activity | $18M | · | $30M | $75M | · | · | $162M | · | · | · | |
| Financing Cash Flow | $14M | $940.0K | $54M | $75M | $156M | $9M | $186M | $358M | $294M | $57M | |
| Net Change in Cash | $3M | $-3M | $13M | $-75M | $-15M | $33M | $40M | $-113M | $131M | $-62M | |
| Free Cash Flow | $-28M | $-24M | $-60M | $-149M | $-206M | $-192M | $-132M | $-201M | $-173M | $-137M |
Kârlılık 6
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 73.3% | 73.2% | 48.8% | · | · | · | · | · | · | · | |
| Operating Margin | -1.6% | -8.0% | -87.1% | -162.2% | -252.3% | -257.4% | -144.3% | -237.4% | -632.4% | -13363.2% | |
| Net Margin | -13.0% | -9.4% | -87.0% | -169.0% | -255.6% | -256.4% | -140.3% | -230.8% | -641.9% | -13537.4% | |
| EBITDA Margin | -0.14% | -6.3% | -84.8% | -159.5% | -248.8% | -254.2% | -142.9% | -235.5% | -627.4% | -13363.2% | |
| ROA | -8.3% | -6.0% | -46.7% | -65.4% | -67.0% | -52.5% | -42.0% | -51.3% | -130.9% | -168.7% | |
| ROE | 312.5% | 36.9% | 358.0% | -1010.6% | -224.7% | -88.5% | -59.4% | -46.0% | -359.4% | -357.5% |
Likidite ve Solventlik 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.5 | 2.3 | 2.4 | 2.5 | 3.6 | 3.1 | 5.0 | 4.9 | 2.2 | 1.6 | |
| Quick Ratio | 1.2 | 1.1 | 1.1 | 0.8 | 1.8 | 1.4 | 1.2 | 4.3 | 2.1 | 1.4 | |
| Interest Coverage | · | · | -28.6 | -70.6 | -90.4 | -120.0 | -143.1 | -68.8 | -49.4 | -64.2 |
Verimlilik 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.6 | 0.5 | 0.4 | 0.3 | 0.2 | 0.3 | 0.2 | 0.2 | 0.0 | |
| Inventory Turnover | 0.6 | 0.8 | 1.3 | 1.1 | 1.0 | 1.1 | 1.9 | 1.1 | 0.6 | 0.0 | |
| Receivables Turnover | 1.8 | 2.1 | 2.3 | 2.5 | 2.2 | 2.2 | 2.8 | 1.5 | 1.4 | 1.3 |
Büyüme Oranları 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 7.4% | 13.6% | 18.0% | 24.7% | -2.6% | · | · | · | · | · | |
| Revenue CAGR 3Y | 12.9% | 18.7% | 12.8% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.8% | · | · | · | · | · | · | · | · | · |
Değerleme (TTM) 10
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $155M | $144M | $127M | $108M | $86M | $89M | $146M | $77M | $31M | $1M | |
| Net Income TTM | $-20M | $-14M | $-111M | $-182M | $-221M | $-227M | $-205M | $-179M | $-197M | $-173M | |
| Market Cap | $245M | $233M | $255M | $298M | $931M | $1.93B | $2.12B | $2.03B | $1M | $516M | |
| P/E | -10.8 | -17.0 | -2.1 | -1.5 | -4.1 | · | · | · | · | · | |
| P/S | 1.6 | 1.6 | 2.0 | 2.8 | 10.8 | 21.8 | 14.5 | 26.2 | 0.0 | 403.1 | |
| P/B | 17.1 | -6.9 | -7.5 | 21.9 | 12.0 | 8.2 | 5.3 | 5.5 | 0.0 | -24.3 | |
| P / Tangible Book | 17.1 | · | · | 21.9 | 12.0 | 8.2 | · | · | · | · | |
| P / Cash Flow | -8.9 | -10.3 | -4.3 | -2.0 | -4.6 | -10.5 | -17.0 | -10.6 | -0.0 | -3.8 | |
| P / FCF | -8.8 | -9.6 | -4.2 | -2.0 | -4.5 | -10.1 | -16.1 | -10.1 | -0.0 | -3.8 | |
| Earnings Yield | -9.2% | -5.9% | -47.1% | -66.8% | -24.5% | · | · | · | · | · |
Gelir Tablosu 14
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $38M | $35M | $41M | $38M | $37M | $39M | $41M | $33M | $36M | $35M | $34M | $31M | $32M | $30M | $30M | $27M | |
| Cost of Revenue | $12M | $11M | $11M | $12M | $10M | $8M | $10M | $9M | $11M | $8M | $10M | $18M | $20M | $17M | $13M | $15M | |
| Gross Profit | $26M | $24M | $29M | $26M | $27M | $30M | $31M | $23M | $26M | $26M | $24M | $13M | $12M | $13M | $17M | $12M | |
| R&D Expense | $3M | $2M | $4M | $3M | $3M | $2M | $3M | $4M | $4M | $5M | $8M | $9M | $13M | $9M | $-14M | $26M | |
| SG&A Expense | $11M | $12M | $13M | $14M | $14M | $13M | $12M | $12M | $14M | $15M | $14M | $16M | $20M | $16M | $34M | $10M | |
| Operating Expenses | $28M | $29M | $29M | $30M | $29M | $27M | $26M | $28M | $32M | $31M | $35M | $38M | $54M | $46M | $10M | $54M | |
| Operating Income | $-2M | $-5M | $38.0K | $-4M | $-2M | $3M | $4M | $-4M | $-6M | $-5M | $-10M | $-25M | $-42M | $-33M | $-20M | $-42M | |
| Other Non-op | $-3M | $-3M | $5M | $-2M | $-744.0K | $-519.0K | $2M | $-390.0K | $-3M | $2M | $0 | $-79.0K | $344.0K | $295.0K | $1M | $-26.0K | |
| Net Income | $-5M | $-8M | $-3M | $-17M | $-2M | $3M | $4M | $-5M | $-9M | $-3M | $-11M | $-25M | $-42M | $-33M | $-20M | $-42M | |
| EPS (Basic) | $-0.03 | $-0.04 | $-0.02 | $-0.10 | $-0.02 | $0.02 | $0.02 | $-0.03 | $-0.06 | $-0.02 | $-0.01 | $-0.17 | $-0.35 | $-0.27 | $-0.11 | $-0.38 | |
| EPS (Diluted) | $-0.03 | $-0.04 | $-0.01 | $-0.10 | $-0.02 | $0.01 | $0.02 | $-0.03 | $-0.06 | $-0.02 | $-0.01 | $-0.17 | $-0.35 | $-0.27 | $-0.11 | $-0.38 | |
| Shares (Basic) | 190,335,000 | 189,646,000 | -311,151,000 | 170,348,000 | 154,020,000 | 153,490,000 | -303,885,000 | 152,830,000 | 152,305,000 | 151,199,000 | -245,820,000 | 144,990,000 | 119,719,000 | 119,246,000 | -207,387,000 | 111,735,000 | |
| Shares (Diluted) | 190,335,000 | 189,646,000 | -354,582,000 | 170,348,000 | 154,020,000 | 196,921,000 | -303,885,000 | 152,830,000 | 152,305,000 | 151,199,000 | -245,820,000 | 144,990,000 | 119,719,000 | 119,246,000 | -207,387,000 | 111,735,000 | |
| EBITDA | $-2M | $-4M | · | $-4M | $-2M | $4M | · | $-4M | $-6M | $-4M | · | $-25M | $-42M | $-32M | · | $-42M |
Bilanço 22
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $21M | $26M | $29M | $43M | $17M | $19M | $26M | $26M | $18M | $20M | · | $35M | $13M | $27M | · | $50M | |
| Receivables | $90M | $84M | $90M | $81M | $80M | $79M | $79M | $67M | $74M | $65M | · | $64M | $77M | $51M | · | $42M | |
| Inventory | $91M | $93M | $93M | $70M | $73M | $57M | $53M | $46M | $43M | $42M | · | $42M | $45M | $52M | · | $52M | |
| Prepaid Expense | $7M | $8M | $9M | $23M | $17M | $26M | $18M | $11M | $7M | $7M | · | $11M | $11M | $15M | · | $8M | |
| Current Assets | $230M | $229M | $238M | $229M | $211M | $213M | $209M | $195M | $191M | $186M | · | $194M | $165M | $178M | · | $224M | |
| PP&E (Net) | $12M | $12M | $12M | $13M | $14M | $15M | $15M | $15M | $16M | $19M | · | $21M | $21M | $22M | · | $23M | |
| PP&E (Gross) | · | · | $25M | · | · | · | $33M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $13M | · | · | · | $18M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $5M | $5M | $5M | $6M | $6M | $6M | $6M | $7M | $7M | $8M | · | $8M | $9M | $14M | · | $17M | |
| Total Assets | $252M | $246M | $256M | $249M | $232M | $236M | $233M | $221M | $218M | $218M | · | $229M | $201M | $221M | · | $272M | |
| Accounts Payable | $12M | $9M | $9M | $12M | $12M | $12M | $12M | $10M | $10M | $837.0K | · | $2M | $2M | $4M | · | $7M | |
| Current Liabilities | $92M | $91M | $96M | $90M | $259M | $89M | $91M | $86M | $80M | $75M | · | $80M | $87M | $78M | · | $94M | |
| Capital Leases | $6M | · | · | · | · | · | · | $522.0K | $1M | $2M | · | $4M | $4M | $5M | · | $6M | |
| Other Non-current Liabilities | $5M | $5M | $5M | $5M | $747.0K | $682.0K | $615.0K | $241.0K | $241.0K | $241.0K | · | $241.0K | $241.0K | $241.0K | · | $241.0K | |
| Total Liabilities | $245M | $237M | $242M | $234M | $259M | $264M | $267M | $261M | $256M | $252M | · | $257M | $241M | $232M | · | $250M | |
| Common Stock | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $1M | $1M | $1M | · | $1M | |
| Paid-in Capital | $1.96B | $1.95B | $1.95B | $1.94B | $1.89B | $1.89B | $1.88B | $1.88B | $1.88B | $1.87B | · | $1.87B | $1.83B | $1.82B | · | $1.80B | |
| Retained Earnings | $-1.95B | $-1.95B | $-1.94B | $-1.94B | $-1.92B | $-1.92B | $-1.92B | $-1.92B | $-1.92B | $-1.91B | · | $-1.90B | $-1.87B | $-1.83B | · | $-1.78B | |
| AOCI | $-6.0K | $-6.0K | $4.0K | $0 | $-1.0K | $1.0K | $13.0K | $40.0K | $-8.0K | $-6.0K | · | $-1.0K | $-6.0K | $9.0K | · | $-57.0K | |
| Stockholders' Equity | $7M | $9M | $14M | $15M | $-27M | $-28M | $-34M | $-40M | $-38M | $-34M | $-34M | $-28M | $-39M | $-11M | $14M | $22M | |
| Liabilities + Equity | $252M | $246M | $256M | $249M | $232M | $236M | $233M | $221M | $218M | $218M | · | $229M | $201M | $221M | · | $272M | |
| Shares Outstanding | · | · | 188,314,430 | · | · | · | 152,127,878 | · | · | · | · | · | · | · | · | · |
Nakit Akışı 10
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $452.0K | $529.0K | $537.0K | $615.0K | $611.0K | $551.0K | $581.0K | $581.0K | $641.0K | $689.0K | $715.0K | $727.0K | $739.0K | $718.0K | $791.0K | $706.0K | |
| Stock-based Comp | $3M | $3M | $2M | $3M | $3M | $3M | $2M | $3M | $5M | $3M | $4M | $7M | $14M | $8M | $11M | $11M | |
| Other Non-cash | · | $3M | · | · | · | $-15M | · | · | · | $-10M | · | · | · | $-797.0K | · | · | |
| Operating Cash Flow | $-2M | $-2M | $-9M | $1M | $-11M | $-9M | $-12M | $3M | $-5M | $-10M | $2M | $-9M | $-27M | $-25M | $-38M | $-37M | |
| CapEx | $138.0K | $391.0K | $0 | $0 | $208.0K | $109.0K | $638.0K | $431.0K | · | · | $250.0K | $793.0K | $278.0K | $224.0K | $414.0K | $45.0K | |
| Investing Cash Flow | $-3M | $-939.0K | $-5M | $12M | $7M | $2M | $11M | $4M | $2M | $1M | $-9M | $-23M | $13M | $37M | $2M | $-36M | |
| Stock Issued | · | · | $-2M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $82.0K | $-51.0K | $219.0K | $13M | $781.0K | $64.0K | $423.0K | $14.0K | $492.0K | $11.0K | $199.0K | $54M | $319.0K | $-208.0K | $439.0K | $75M | |
| Net Change in Cash | $-5M | $-3M | $-14M | $27M | $-3M | $-7M | $61.0K | $7M | $-2M | $-8M | $-6M | $21M | $-14M | $12M | $-35M | $2M | |
| Free Cash Flow | · | $-2M | · | · | · | $-9M | · | · | · | · | · | · | · | $-25M | · | · |
Kârlılık 6
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 69.3% | 69.3% | · | 68.8% | 73.5% | 78.3% | · | 71.2% | 70.8% | 75.6% | · | 42.1% | · | · | · | · | |
| Operating Margin | -5.4% | -13.7% | · | -10.7% | -4.4% | 8.1% | · | -13.6% | -17.9% | -13.8% | · | -79.3% | -133.5% | -111.6% | · | -157.7% | |
| Net Margin | -14.6% | -23.4% | · | -45.8% | -6.4% | 6.8% | · | -14.8% | -25.6% | -9.1% | · | -79.6% | -132.4% | -110.7% | · | -157.8% | |
| EBITDA Margin | -5.4% | -12.2% | · | -10.7% | -4.4% | 9.5% | · | -13.6% | -17.9% | -11.8% | · | -79.3% | -133.5% | -109.2% | · | -157.7% | |
| ROA | -2.3% | -3.4% | · | -7.4% | -1.1% | 1.2% | · | -2.1% | -4.4% | -1.4% | · | -10.0% | -18.9% | -13.2% | · | -13.4% | |
| ROE | 53.9% | 84.0% | · | 139.3% | 7.3% | -8.5% | · | 14.3% | 23.9% | 14.0% | · | 937.3% | 137.8% | -523.1% | · | -59.3% |
Likidite ve Solventlik 2
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.5 | 2.5 | · | 2.6 | 0.8 | 2.4 | · | 2.3 | 2.4 | 2.5 | · | 2.4 | 1.9 | 2.3 | · | 2.4 | |
| Quick Ratio | 1.2 | 1.2 | · | 1.4 | 0.4 | 1.1 | · | 1.1 | 1.1 | 1.1 | · | 1.2 | 1.0 | 1.0 | · | 1.0 |
Verimlilik 3
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.1 | · | 0.2 | 0.2 | 0.2 | · | 0.1 | 0.2 | 0.2 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.1 | 0.1 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.4 | 0.4 | 0.3 | · | 0.3 | |
| Receivables Turnover | 0.4 | 0.4 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.6 | · | 0.6 | 0.5 | 0.6 | · | 0.6 |
Değerleme (TTM) 4
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $148M | $149M | · | $147M | $145M | $142M | · | $135M | $134M | $127M | · | $119M | $116M | $107M | · | $101M | |
| Net Income TTM | $-33M | $-25M | · | $-22M | $-14M | $-15M | · | $-42M | $-79M | $-103M | · | $-142M | $-173M | $-195M | · | $-215M | |
| P/E | -2.3 | -5.3 | · | -9.0 | -20.7 | -22.0 | · | -7.1 | -5.8 | -3.4 | · | -0.9 | -0.7 | -0.8 | · | -2.0 | |
| Earnings Yield | -44.2% | -18.8% | · | -11.1% | -4.8% | -4.5% | · | -14.1% | -17.1% | -29.2% | · | -113.6% | -133.6% | -121.2% | · | -49.0% |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Gelir | $155M | $144M | $127M | $108M | $86M |
| Brüt Kâr Marjı % | 73.3% | 73.2% | 48.8% | — | — |
| Faaliyet Kâr Marjı % | -1.6% | -8.0% | -87.1% | -162.2% | -252.3% |
| Net Gelir | $-20M | $-14M | $-111M | $-182M | $-221M |
| Seyreltilmiş Hisse Başı Kâr | $-0.12 | $-0.09 | $-0.80 | $-1.67 | $-2.24 |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Cari Oran | 2.5 | 2.3 | 2.4 | 2.5 | 3.6 |
| Cari Oran | 1.2 | 1.1 | 1.1 | 0.8 | 1.8 |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-28M | $-24M | $-60M | $-149M | $-206M |
Son Haberler Bu şirketten bahseden son manşetler
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kurumsal Sahipler (13F) 184 dosya · $51.8M toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 25 (-7 önceki Ç'ye göre) | 21 (-6 önceki Ç'ye göre) | 50 (+3 önceki Ç'ye göre) | 40 (-6 önceki Ç'ye göre) | -15.3M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| Rubric Capital Management LP | $12.823.986 | 30.046.828 | 24,76% | Hisse senetleri |
| Clearline Capital LP | $4.858.675 | 11.383.961 | 9,38% | Hisse senetleri |
| Velan Capital Investment Management LP | $3.735.904 | 8.753.290 | 7,21% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $3.323.230 | 7.782.741 | 6,42% | Hisse senetleri |
| Tejara Capital Ltd | $2.778.807 | 6.510.795 | 5,36% | Hisse senetleri |
| TANG CAPITAL MANAGEMENT LLC | $2.667.500 | 6.250.000 | 5,15% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $1.737.119 | 4.070.101 | 3,35% | Hisse senetleri |
| JW Asset Management, LLC | $1.600.958 | 3.751.073 | 3,09% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $1.543.336 | 3.614.773 | 2,98% | Hisse senetleri |
| VANGUARD GROUP INC | $1.500.729 | 1.154.407 | 2,90% | Hisse senetleri |
| Stonepine Capital Management, LLC | $1.500.000 | 1.000.000 | 2,90% | Alım opsiyonu |
| STATE STREET CORP | $1.377.948 | 3.228.557 | 2,66% | Hisse senetleri |
| Pale Fire Capital SE | $1.071.899 | 2.511.478 | 2,07% | Hisse senetleri |
| Caption Management, LLC | $896.280 | 2.100.000 | 1,73% | Satım opsiyonu |
| Congress Park Capital LLC | $860.620 | 2.016.447 | 1,66% | Hisse senetleri |
| TWO SIGMA ADVISERS, LP | $675.442 | 519.571 | 1,30% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $674.878 | 1.580.510 | 1,30% | Hisse senetleri |
| RENAISSANCE TECHNOLOGIES LLC | $643.145 | 1.506.900 | 1,24% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $582.906 | 1.365.119 | 1,13% | Hisse senetleri |
| PANAGORA ASSET MANAGEMENT INC | $547.071 | 1.281.796 | 1,06% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $519.613 | 1.217.463 | 1,00% | Hisse senetleri |
| Qube Research & Technologies Ltd | $435.802 | 1.021.092 | 0,84% | Hisse senetleri |
| Caption Management, LLC | $426.800 | 1.000.000 | 0,82% | Hisse senetleri |
| CM Management, LLC | $426.800 | 1.000.000 | 0,82% | Hisse senetleri |
| NEW YORK STATE COMMON RETIREMENT FUND | $296.270 | 694.165 | 0,57% | Hisse senetleri |
| ALLIANCEBERNSTEIN L.P. | $239.958 | 299.910 | 0,46% | Hisse senetleri |
| Stonepine Capital Management, LLC | $209.468 | 490.787 | 0,40% | Hisse senetleri |
| DIADEMA PARTNERS LP | $195.783 | 458.723 | 0,38% | Hisse senetleri |
| Xcelsior Advisor Partners LLC | $173.186 | 405.777 | 0,33% | Hisse senetleri |
| Apeiron RIA LLC | $158.163 | 370.579 | 0,31% | Hisse senetleri |
| Squarepoint Ops LLC | $137.078 | 321.177 | 0,26% | Hisse senetleri |
| Integrated Wealth Concepts LLC | $136.107 | 318.903 | 0,26% | Hisse senetleri |
| Glenmede Investment Management, LP | $132.710 | 105.326 | 0,26% | Hisse senetleri |
| Richmond Brothers, Inc. | $131.755 | 308.706 | 0,25% | Hisse senetleri |
| TWO SIGMA INVESTMENTS, LP | $113.663 | 266.314 | 0,22% | Hisse senetleri |
| MARSHALL WACE, LLP | $105.194 | 244.638 | 0,20% | Hisse senetleri |
| NEXPOINT ASSET MANAGEMENT, L.P. | $99.359 | 232.800 | 0,19% | Hisse senetleri |
| FMR LLC | $96.800 | 226.803 | 0,19% | Hisse senetleri |
| Abel Hall, LLC | $90.987 | 213.185 | 0,18% | Hisse senetleri |
| CAROLINAS WEALTH CONSULTING LLC | $90.983 | 41.356 | 0,18% | Hisse senetleri |
| Horan Securities, Inc. | $86.091 | 41.590 | 0,17% | Hisse senetleri |
| RHUMBLINE ADVISERS | $83.482 | 195.537 | 0,16% | Hisse senetleri |
| Cutter & CO Brokerage, Inc. | $80.223 | 36.465 | 0,15% | Hisse senetleri |
| Quinn Opportunity Partners LLC | $74.837 | 175.344 | 0,14% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $74.770 | 175.188 | 0,14% | Hisse senetleri |
| DLK Investment Management, LLC | $62.615 | 17.890 | 0,12% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $58.500 | 137.067 | 0,11% | Hisse senetleri |
| Bank of New York Mellon Corp | $54.073 | 126.693 | 0,10% | Hisse senetleri |
| D. E. Shaw & Co., Inc. | $51.402 | 120.435 | 0,10% | Hisse senetleri |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $51.341 | 120.293 | 0,10% | Hisse senetleri |
| Persistent Asset Partners Ltd | $49.974 | 117.090 | 0,10% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $48.289 | 112.300 | 0,09% | Alım opsiyonu |
| BANK OF AMERICA CORP /DE/ | $46.165 | 108.369 | 0,09% | Hisse senetleri |
| Redwood Family Wealth LLC | $45.015 | 105.472 | 0,09% | Hisse senetleri |
| Biltmore Family Office, LLC | $42.680 | 100.000 | 0,08% | Hisse senetleri |
| DEUTSCHE BANK AG\ | $41.409 | 96.300 | 0,08% | Hisse senetleri |
| IEQ CAPITAL, LLC | $41.234 | 96.612 | 0,08% | Hisse senetleri |
| BARCLAYS PLC | $37.172 | 87.094 | 0,07% | Hisse senetleri |
| SEARLE & CO. | $36.812 | 86.250 | 0,07% | Hisse senetleri |
| Vanguard Global Advisers, LLC | $35.764 | 83.756 | 0,07% | Hisse senetleri |
| BlackRock, Inc. | $35.761 | 83.788 | 0,07% | Hisse senetleri |
| Russell Investments Group, Ltd. | $34.675 | 81.246 | 0,07% | Hisse senetleri |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $31.406 | 73.585 | 0,06% | Hisse senetleri |
| MERCER GLOBAL ADVISORS INC /ADV | $29.147 | 68.291 | 0,06% | Hisse senetleri |
| CITIGROUP INC | $28.050 | 65.721 | 0,05% | Hisse senetleri |
| Invesco Ltd. | $27.051 | 63.382 | 0,05% | Hisse senetleri |
| LPL Financial LLC | $26.083 | 61.112 | 0,05% | Hisse senetleri |
| COMMONWEALTH EQUITY SERVICES, LLC | $25.254 | 59.176 | 0,05% | Hisse senetleri |
| Anfield Capital Management, LLC | $24.003 | 30.000 | 0,05% | Hisse senetleri |
| Mariner, LLC | $23.896 | 55.972 | 0,05% | Hisse senetleri |
| NICOLET ADVISORY SERVICES, LLC | $23.840 | 16.000 | 0,05% | Hisse senetleri |
| Chicago Partners Investment Group LLC | $23.526 | 51.254 | 0,05% | Hisse senetleri |
| CWM, LLC | $23.115 | 28.890 | 0,04% | Hisse senetleri |
| Cerity Partners LLC | $22.473 | 52.654 | 0,04% | Hisse senetleri |
| CAPTRUST FINANCIAL ADVISORS | $22.000 | 51.547 | 0,04% | Hisse senetleri |
| RAYMOND JAMES FINANCIAL INC | $20.003 | 46.868 | 0,04% | Hisse senetleri |
| R Squared Ltd | $19.935 | 46.708 | 0,04% | Hisse senetleri |
| Centiva Capital, LP | $19.422 | 45.507 | 0,04% | Hisse senetleri |
| Nuveen Asset Management, LLC | $19.408 | 12.685 | 0,04% | Hisse senetleri |
| INTECH INVESTMENT MANAGEMENT LLC | $17.990 | 42.150 | 0,03% | Hisse senetleri |
| HORAN Wealth, LLC | $17.751 | 41.590 | 0,03% | Hisse senetleri |
| Prospera Financial Services Inc | $17.308 | 40.565 | 0,03% | Hisse senetleri |
| Cornerstone Select Advisors, LLC | $17.057 | 39.964 | 0,03% | Hisse senetleri |
| NEUBERGER BERMAN GROUP LLC | $16.647 | 38.987 | 0,03% | Hisse senetleri |
| Police & Firemen's Retirement System of New Jersey | $16.369 | 38.352 | 0,03% | Hisse senetleri |
| GROUP ONE TRADING LLC | $16.196 | 37.947 | 0,03% | Hisse senetleri |
| Creative Planning | $15.306 | 35.862 | 0,03% | Hisse senetleri |
| Tower Research Capital LLC (TRC) | $15.180 | 35.567 | 0,03% | Hisse senetleri |
| HSBC HOLDINGS PLC | $14.464 | 33.381 | 0,03% | Hisse senetleri |
| DDFG, Inc | $14.043 | 32.903 | 0,03% | Hisse senetleri |
| Concurrent Investment Advisors, LLC | $13.625 | 31.923 | 0,03% | Hisse senetleri |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $13.425 | 32.397 | 0,03% | Hisse senetleri |
| CIBC WORLD MARKETS CORP | $13.215 | 10.165 | 0,03% | Hisse senetleri |
| Skopos Labs, Inc. | $12.744 | 15.927 | 0,02% | Hisse senetleri |
| CoreCap Advisors, LLC | $12.125 | 28.409 | 0,02% | Hisse senetleri |
| Vanguard Personalized Indexing Management, LLC | $11.641 | 27.276 | 0,02% | Hisse senetleri |
| DIVERSIFIED TRUST CO | $11.306 | 26.492 | 0,02% | Hisse senetleri |
| CITADEL ADVISORS LLC | $11.139 | 26.100 | 0,02% | Alım opsiyonu |
| Pallas Capital Advisors LLC | $10.968 | 25.699 | 0,02% | Hisse senetleri |
| JANE STREET GROUP, LLC | $10.957 | 25.672 | 0,02% | Hisse senetleri |
Şirket yöneticileri 39 içeriden öğrenenler · 21 yöneticiler · 21 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Craig A Collard | Chief Executive Officer | 31 Temmuz 2026 M | 856.492 | 0 | 0 | $0 |
| Barry D Quart | Chief Executive Officer | 18 Ocak 2023 A | 177.989 | 0 | 0 | $0 |
| Ronald J Prentki | President & CEO | 17 Şubat 2010 A | 40.539 | 0 | 0 | $0 |
| Michael Oconnell | Chief Executive Officer | 10 Ocak 2006 A | 132.200 | 0 | 0 | $0 |
| Ira Duarte | EVP, Chief Financial Officer | 31 Temmuz 2026 M | 281.899 | 0 | 0 | $0 |
| Robert Hoffman | CFO & SVP, Finance | 19 Aralık 2019 A | 1.280 | 0 | 0 | $0 |
| Brian G. Drazba | VP, Finance & CFO | 31 Ekim 2016 J | 3.798 | 0 | 0 | $0 |
| John Whelan | CFO | 18 Temmuz 2013 M | 254.088 | 0 | 0 | $0 |
| Stephen Whiteford | V.P., Finance & CFO | 15 Aralık 2006 A | 15.000 | 0 | 0 | $0 |
| John Poyhonen | President & CCO | 13 Nisan 2023 M | 46.648 | 0 | 0 | $0 |
| Robert Rosen | President | 15 Aralık 2018 A | 2.640 | 0 | 0 | $0 |
| David Leslie Szekeres | EVP, Chief Operating Officer | 13 Temmuz 2023 M | 33.754 | 0 | 0 | $0 |
| Michael A Adam | Chief Operating Officer | 08 Şubat 2013 A | — | 0 | 0 | $0 |
| William P Forbes | EVP, Chief Development Officer | 31 Temmuz 2026 M | 241.173 | 0 | 0 | $0 |
| Lisa Peraza | VP, Chief Accounting Officer | 19 Ocak 2024 A | 55.907 | 0 | 0 | $0 |
| Kimberly Manhard | EVP, Drug Development | 13 Nisan 2023 M | 28.330 | 0 | 0 | $0 |
| Marshall Paul | SVP, Technical Operations | 21 Mart 2016 M | 2.200 | 0 | 0 | $0 |
| Neil James Clendeninn | SVP & Chief Medical Officer | 12 Ekim 2015 A | — | 0 | 0 | $0 |
| Mark S. Gelder MD | SVP & Chief Medical Officer | 12 Aralık 2014 A | — | 0 | 0 | $0 |
| John Barr | Vice President of R&D | 08 Temmuz 2011 A | 51.772 | 0 | 0 | $0 |
| Anastassios D. Retzios | VP of Clinical Development | 15 Ocak 2008 A | — | 0 | 0 | $0 |
| Thomas Cusack | Yönetim kurulu üyesi | 30 Ocak 2026 A | 53.960 | 0 | 0 | $0 |
| Morgan Adam | Yönetim kurulu üyesi | 30 Ocak 2026 A | 123.737 | 0 | 0 | $0 |
| Sharmila Dissanaike | Yönetim kurulu üyesi | 30 Ocak 2026 A | 53.960 | 0 | 0 | $0 |
| Michael Kaseta | Yönetim kurulu üyesi | 30 Ocak 2026 A | 53.960 | 0 | 0 | $0 |
| Waage Christian | Yönetim kurulu üyesi | 30 Ocak 2026 A | 53.960 | 0 | 0 | $0 |
| Craig A Johnson | Yönetim kurulu üyesi | 30 Ocak 2026 A | 53.960 | 0 | 0 | $0 |
| Susan Rodriguez | Yönetim kurulu üyesi | 31 Ocak 2025 A | 87.180 | 0 | 0 | $0 |
| Stephen Davis | Yönetim kurulu üyesi | 16 Aralık 2022 A | 52.032 | 0 | 0 | $0 |
| KEVIN TANG | Yönetim kurulu üyesi | 19 Aralık 2019 A | 5.799.810 | 0 | 0 | $0 |
| Greg Turnbull | Yönetim kurulu üyesi | 29 Mayıs 2012 A | 245.092 | 0 | 0 | $0 |
| Paul Goddard | Yönetim kurulu üyesi | 29 Mayıs 2012 A | 214.683 | 0 | 0 | $0 |
| Toby Rosenblatt | Yönetim kurulu üyesi | 20 Mayıs 2010 A | 210.234 | 0 | 0 | $0 |
| Robert L Zerbe MD | Yönetim kurulu üyesi | 20 Mayıs 2010 A | 202.072 | 0 | 0 | $0 |
| Peter Riepenhausen | Yönetim kurulu üyesi | 28 Mayıs 2008 A | 9.000 | 0 | 0 | $0 |
| Arthur T Taylor | Yönetim kurulu üyesi | 28 Mayıs 2008 A | 12.000 | 0 | 0 | $0 |
| Dennis L Winger | Yönetim kurulu üyesi | 11 Ağustos 2006 A | 69.544 | 0 | 0 | $0 |
| Stephen A Drury | Yönetim kurulu üyesi | 11 Ağustos 2006 J | 83.283 | 0 | 0 | $0 |
| Mark Earl Hensley | — | 06 Ağustos 2026 M | 170.901 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
Aktivistler ve %5+ sahipler 3 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Rubric Capital Management LP, David Rosen ×6 başvurular | 17 Ekim 2025 | 15,90% | Değişiklik | — | SEC |
| Tang Capital Partners, LP, Tang Capital Management, LLC, Kevin Tang ×20 başvurular | 07 Ocak 2020 | — | İlk başvuru | — | SEC |
| Felix J. Baker, Julian C. Baker ×3 başvurular | 07 Temmuz 2011 | — | İlk başvuru | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF sahipliği 22 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,28% | 128.515 SH | 08 Ağustos 2026 | Günlük |
| IWC · iShares Trust | 0,02% | 537.335 SH | 08 Ağustos 2026 | Günlük |
| RSSL · Global X Funds | 0,01% | 67.617 NS | 30 Nisan 2026 | N-PORT |
| IWO · iShares Trust | 0,00% | 1.328.289 SH | 08 Ağustos 2026 | Günlük |
| ITWO · ProShares Trust | 0,00% | 7.231 NS | 31 Mayıs 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,00% | 198.683 SH | 08 Ağustos 2026 | Günlük |
| SCHA · SCHWAB STRATEGIC TRUST | 0,00% | 869.904 NS | 31 Mayıs 2026 | N-PORT |
| IWM · iShares Trust | 0,00% | 3.609.893 SH | 08 Ağustos 2026 | Günlük |
| UWM · ProShares Trust | 0,00% | 5.655 NS | 31 Mayıs 2026 | N-PORT |
| IWN · iShares Trust | 0,00% | 505.371 SH | 08 Ağustos 2026 | Günlük |
| URTY · ProShares Trust | 0,00% | 5.714 NS | 31 Mayıs 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 144 NS | 31 Mayıs 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 4.190 NS | 31 Mayıs 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 83.361 NS | 31 Mayıs 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 28.626 SH | 08 Ağustos 2026 | Günlük |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 2.063.361 SH | 08 Ağustos 2026 | Günlük |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 5.474.947 SH | 08 Ağustos 2026 | Günlük |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,00% | 925.988 SH | 08 Ağustos 2026 | Günlük |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,00% | 13.208 SH | 08 Ağustos 2026 | Günlük |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 156.616 SH | 08 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 12.513 SH | 08 Ağustos 2026 | Günlük |
| VHT · VANGUARD WORLD FUND | 0,00% | 472.185 SH | 08 Ağustos 2026 | Günlük |